Key result
High-sensitivity cardiac troponin assays increase diagnostic accuracy for myocardial infarction at emergency department presentation, reducing the time required for safe rule-out or rule-in.
Answers are grounded in this paper and cite their sources.
High-sensitivity cardiac troponin assays enable precise quantification of cardiomyocyte injury, improving early diagnostic accuracy and reducing time for MI rule-in/rule-out.
High-sensitivity cardiac troponin (hs-cTn) assays have been used clinically in many countries throughout the world for years and complement detailed clinical assessment and the electrocardiogram in the early diagnosis of myocardial infarction (MI). High-sensitivity cardiac troponin assays for the first time allow to precisely quantify cardiomyocyte injury around the 99th percentile and thereby substantially increase the accuracy for MI already for blood draws obtained at presentation to the emergency department (ED). Higher diagnostic accuracy at ED presentation enabled the development and extensive validation of early hs-cTn-based diagnostic algorithms, which substantially reduced the time required for safe rule-out or rule-in of MI.
No takes yet. Share an insight, caveat, or question.
Twerenbold et al. (2018) conducted a review in suspected myocardial infarction. High-sensitivity cardiac troponin (hs-cTn) assays was evaluated. High-sensitivity cardiac troponin assays increase diagnostic accuracy for myocardial infarction at emergency department presentation, reducing the time required for safe rule-out or rule-in.
Synapse has enriched 10 related papers. Consider them for comparative context: